Stimvia develops URIS®, a clinically validated, non‑invasive neuromodulation system that stimulates sub‑dermal nerves to treat chronic overactive bladder (OAB). The handheld device delivers targeted electrical pulses without needles or surgery and syncs with a mobile app for real‑time data collection and personalized therapy optimization, offering a drug‑free alternative with efficacy comparable to invasive procedures.
Funding
Funding not disclosed
Founders
Product
Problem
Patients with overactive bladder (OAB) often rely on long‑term medication or invasive procedures, which can cause side effects, require surgery, or fail to provide adequate symptom relief.
Solution
Stimvia offers URIS®, a clinically validated neuromodulation system that non‑invasively stimulates sub‑dermal nerves to treat chronic OAB. The handheld device delivers targeted electrical pulses without needles or surgery, reducing bladder urgency and frequency. Integrated with a mobile application, URIS® collects treatment data in real time, enabling clinicians to personalize therapy parameters for each patient. Clinical studies show URIS® achieves efficacy comparable to invasive options while maintaining a low risk profile. The solution provides a drug‑free alternative for patients who have not responded to medication and prefer a minimally risky intervention.
Target Audience
Primary customers are urologists and urogynecologists treating patients with OAB who have failed pharmacologic therapy and seek a non‑surgical, low‑risk alternative.
Features
- Non‑invasive, wearable neuromodulation device that targets sub‑dermal nerves to modulate bladder activity
- Clinically proven efficacy in reducing OAB symptoms, comparable to invasive therapies
- Mobile app for continuous data capture, remote monitoring, and individualized parameter optimization
- Automated treatment protocols with adjustable pulse settings to match patient-specific needs
- No needles, no surgery, and minimal side‑effect risk, supporting outpatient or home use
- Reusable hardware designed for shared use, constructed from 90 % recyclable and 30 % recycled materials